{"ORPHApacket":[{"ORPHApacketID":"35705","date":"2019-12-06 08:45:38","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"35705","Name":[{"lang":"en","label":"Neurometabolic disorder due to serine deficiency"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_35705","DisorderType":[{"Name":[{"lang":"en","label":"Category"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_557495"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Neurometabolic disease"}],"ORPHA":"68385","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_68385"},{"Name":[{"lang":"en","label":"Disorder of serine or glycine metabolism"}],"ORPHA":"79194","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_79194"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Serine-deficiency syndrome is a very rare infantile-onset potentially treatable neurometabolic disorder characterized clinically by microcephaly, neurodevelopmental disorders and seizures. Three serine-deficiency syndromes have been described: 3-phosphoglycerate dehydrogenase (3-PGDH) deficiency, 3-phosphoserine phosphatase (3-PSP) deficiency, and phosphoserine aminotransferase deficiency (see these terms)."}],"AverageAgeOfOnsetList":[{"count":"2","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Infancy"}]},{"Name":[{"lang":"en","label":"Neonatal"}]}]}],"SynonymList":[{"count":"1","Synonym":[{"lang":"en","label":"Serine deficiency"}]}]}]}